Elizabeth Warren @ewarren
Truvada’s manufacturer, Gilead, relied on $50 million in federal grants to develop it, but today they rake in multi-billion dollar profits while Americans struggle to afford it. Only a fraction of patients benefit from it, thanks to its hefty $2,000-a-month price tag. https://t.co/sYGb1hb7ty — PolitiTweet.org